Core Insights - PetVivo Holdings, Inc. has launched PetVivo.ai, an AI platform aimed at transforming the $150 billion pet care market by significantly reducing customer acquisition costs for veterinary practices [1][3][4] - The company is shifting from traditional medical device sales to a high-margin AI Software-as-a-Service (SaaS) model, which offers recurring revenue and scalability [2][5] Industry Context - The pet care industry exceeds $150 billion annually, with Gen Z and Millennial pet owners making up 57% of all pet owners, who expect modern digital experiences [3] - Veterinary practices currently rely on outdated marketing methods, leading to high customer acquisition costs ranging from $80 to $400 per new client [3][4] Company Strategy - PetVivo.ai utilizes nine specialized AI agents to connect veterinary practices with engaged pet parents, generating qualified leads at a cost of $3 per pet parent, compared to traditional methods costing $15 to $45 [4][6] - The platform's beta program showed that the median practice acquired 47 new clients over six months at a blended customer acquisition cost of $42.53, achieving significant savings [4][6] Financial Metrics - The platform is expected to achieve gross margins of 80-90% and a lifetime value to customer acquisition cost (LTV/CAC) ratio of 25:1 [6] - Projections indicate that by Year 1, the company could reach $12 million in annual recurring revenue (ARR) with 500 practices, scaling to $360 million ARR with 10,000 practices by Year 5 [6] Market Opportunity - PetVivo.ai targets approximately 30,000 U.S. veterinary practices and over 100,000 globally, with strong scaling potential even under conservative adoption forecasts [5][6] - The launch is seen as a catalyst for re-evaluating the company's valuation, transitioning from traditional medical device revenue multiples of 1-2x to AI SaaS multiples of 15-30x [5][7] Competitive Advantages - PetVivo.ai holds a first-mover advantage with no direct AI competitors and strong two-sided network effects, supported by existing relationships with 1,200 veterinary clinic distributors [7] - Deep integrations with practice management systems are expected to facilitate adoption and reduce onboarding friction [7] Commercial Launch - Following successful beta testing, PetVivo.ai is now fully commercial with open sign-ups, offering a 14-day free trial and three pricing tiers [8]

Core Insights - ZenaTech, Inc. has opened a new office in the Washington, D.C. area to enhance its engagement with federal government and defense agencies, aiming to establish a strong federal presence for defense revenue growth [1][2] - The company is expanding its manufacturing facility in Mesa, Arizona, tripling the size to support full U.S. drone assembly, production, and testing, which aligns with its strategy to increase operational capacity and meet the growing demand for advanced UAV systems [2][3] Company Overview - ZenaTech specializes in AI drone technology, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, focusing on mission-critical applications across various sectors including defense, agriculture, and logistics [3][6] - The company operates globally with offices in North America, Europe, Taiwan, and the UAE, and is actively growing its U.S. DaaS business through acquisitions [3] Product Offerings - ZenaTech's drone portfolio includes the ZenaDrone 1000, capable of lifting approximately 40 kg, designed for inspection, surveillance, and reconnaissance applications, and has been tested by the U.S. Air Force and Navy Reserve [5][6] - The IQ Square and IQ Nano drones serve specific functions such as land surveys, infrastructure inspections, and inventory management in GPS-denied environments, showcasing the versatility of ZenaTech's drone solutions [5][6]

Core Insights - Dragonfly Energy Holdings Corp. is expanding its Battle Born® product portfolio with new inverter/chargers, Base Series batteries, and a redesigned mobile app, enhancing its position as a complete power solutions provider across various markets [1][5] Product Expansion - The new Battle Born Inverter/Charger Series features pure sine wave models with advanced power control and inverter assist functions for efficient power management, equipped with Dragonfly IntelLigence® technology and compatible with the Battle Born mobile app for real-time monitoring [2] - The Battle Born Base Series Batteries are designed for a broader, value-conscious market, providing a modern LiFePO₄ alternative to traditional sealed lead-acid units, suitable for portable and auxiliary power needs [3] - The updated Battle Born Mobile App V2.0 offers a redesigned interface and optimized backend for better system control, allowing users to monitor and adjust settings in real time, and introduces RV-C integration for interoperability with third-party platforms [4] Strategic Vision - The CEO of Dragonfly Energy emphasized that the expansion of the product ecosystem marks a pivotal moment in the company's evolution, focusing on delivering a fully integrated power system that enhances customer control and confidence [5] - The new products are available for sale as part of the annual Black Friday sales event, with the mobile app launching on November 28, 2025, and additional product releases planned throughout 2026 [5] Company Overview - Dragonfly Energy is a leader in lithium battery technology, specializing in cell manufacturing, battery pack assembly, and full system integration, with a mission focused on the future deployment of proprietary, nonflammable, all-solid-state battery cells [7]

Core Insights - reAlpha Tech Corp. has acquired Prevu Inc., expanding its real estate footprint into 11 new markets and enhancing its technology-driven platform [1][3] - Prevu is a digital homebuying platform with a rebate-oriented brokerage model, having completed over 1,000 transactions and maintaining a 5-star Google rating [2][4] - The acquisition aims to unify realty and mortgage capabilities, supporting a broader national footprint and enhancing operational capabilities [1][3] Company Overview - reAlpha Tech Corp. is an AI-powered real estate technology company focused on transforming the U.S. real estate services market through an end-to-end platform that integrates brokerage, mortgage, and title services [5] - Prevu operates in major metropolitan markets across 12 states and Washington, D.C., providing a digital platform designed to empower homebuyers with greater control and transparency [4] Strategic Implications - The integration of Prevu's brokerage operations with reAlpha's existing real estate services is expected to accelerate reAlpha's long-term platform strategy and enhance operational efficiency [3] - Both companies share a commitment to modernizing real estate through technology, which is anticipated to create significant opportunities for scaling and delivering value to homebuyers and agents [3][2]

VANCOUVER, British Columbia, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) (“Highland Copper” or the “Company”) is pleased to announce that it has signed a binding offer from its joint venture partner, Kinterra Copper USA LLC (“Kinterra”), for the sale of the Company’s 34% interest in the White Pine North Project (“White Pine”) for aggregate consideration of approximately US$30 million. This transaction represents a significant milestone in optimizing Highland Coppe ...

Core Insights - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on genetic diseases, aiming to discover, create, test, and deliver transformative medicines [2] Company Overview - Founded in 2015, BridgeBio has a pipeline that spans from early science to advanced clinical trials, with a commitment to applying advances in genetic medicine [2] - The company is staffed by experienced professionals in drug discovery and development [2] Upcoming Events - Management will participate in fireside chats at the Piper Sandler Healthcare Conference on December 2 at 10:30 am EST and the EvercoreISI HealthCONx Conference on December 3 at 3:00 pm EST [3] - Live webcasts of these presentations will be accessible on the BridgeBio website, with replays available for 90 days post-event [1]

Core Points - Parsons Corporation will participate in a fireside chat at the Goldman Sachs Industrials and Materials Conference on December 3, 2025 [1] - The session will feature Carey Smith, chair, president, and CEO, and Matt Ofilos, CFO [1] - The presentation will be available live via webcast and can be accessed on the investor relations section of Parsons' website [2] Company Overview - Parsons Corporation is a leading provider of disruptive technology in national security and global infrastructure markets [3] - The company has capabilities in various sectors including cyber and electronic warfare, space and missile defense, transportation, water and environment, urban development, and critical infrastructure protection [3]

Core Insights - Creative Realities, Inc. has appointed Tamra Koshewa as the new Chief Financial Officer effective December 1, 2025, to oversee the next phase of the company's expansion [1][2] - Ms. Koshewa brings 30 years of financial experience across various industries, which will be crucial for integrating the recently acquired Cineplex Digital Media and achieving revenue growth and operational synergies [1][2] Company Overview - Creative Realities specializes in digital signage, media, and AdTech solutions, providing services across multiple sectors including retail, automotive, and digital-out-of-home advertising [4] - The company utilizes platforms such as Clarity™, ReflectView™, and iShowroom™ for content management and aims to enhance customer experiences and productivity through its services [4] Leadership Background - Tamra Koshewa has held CFO positions at Manna, LLFlex, and HMI, and has extensive experience in senior financial roles at companies like Equipment Depot and General Electric [3] - She is recognized for her ability to drive change, implement process improvements, and generate positive cash flow, making her well-suited for the challenges ahead at Creative Realities [2][3]

Core Viewpoint - Anavex Life Sciences Corp. reported its financial results for the fourth quarter of fiscal 2025, highlighting its focus on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease, and the progress of its lead drug candidate, blarcamesine [2][3]. Financial Highlights - Cash and cash equivalents stood at $102.6 million as of September 30, 2025, down from $132.2 million a year earlier, with a current cash balance of over $120 million, indicating a cash runway of more than three years [11]. - Research and development expenses for the quarter were $7.3 million, a decrease from $11.6 million in the same quarter of fiscal 2024 [11]. - General and administrative expenses increased to $3.5 million from $2.7 million year-over-year [11]. - The net loss for the quarter was $9.8 million, or $0.11 per share, compared to a net loss of $11.6 million, or $0.14 per share in the fourth quarter of fiscal 2024 [11]. Recent Corporate Developments - Anavex announced a negative trend vote from the CHMP regarding the Marketing Authorisation Application for blarcamesine, with plans to request a re-examination [11]. - The company is advancing its clinical pipeline, including updates on blarcamesine for early Alzheimer's disease, Parkinson's disease, and Rett syndrome, as well as the development of ANAVEX3-71 for schizophrenia [6][11]. - New scientific findings related to blarcamesine's effects on cognitive function and brain atrophy were presented, reinforcing its therapeutic potential [6][11]. Expected Development Milestones - Anavex is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, showcasing its ongoing commitment to addressing unmet needs in neurodegenerative disorders [11].

CHARLOTTE, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) (“Terrestrial Energy” or “the Company”), a developer of small modular nuclear power plants using its Generation IV reactor technology, announced today that the Company will be participating in the following investor conferences: B. Riley Securities Convergence Conference: AI, Blockchain & Energy on December 4th, 2025, in New York City.2nd Annual Craig-Hallum Nuclear Energy Forum on December 11th, 2025, (virtual). Membe ...